Therapy of ascites in patients with hepatitis C liver cirrhosis: Systemic meta-analysis cohort study
نویسندگان
چکیده
The 12th leading cause of death in the United States is cirrhosis. Recent studies have shown that liver fibrosis an ever-evolving process and early cirrhosis may be reversible. One three people with unaware their condition. most well-known reasons for are viral hepatitis C, alcoholic sickness, nonalcoholic steatohepatitis. aim study to compare different therapeutic approaches patients due C ascites systemic meta‐analysis study. In this study, we looked through Embase, MEDLINE, Science Reference Record Extended, preliminary registers until December 2022 distinguish randomized clinical preliminaries because ascites. comprised 2344 revised articles. Roughly 30.3% members got paracentesis addition liquid substitution. A transjugular intrahepatic portosystemic shunt was associated a higher rate resolution at maximal follow-up (HR 5.22; 95% CrI 1.97 76.67) adding aldosterone adversaries substitution 20.22; 4.03 434.91) contrasted (extremely low-sureness proof). conclusion, light extremely low-assurance proof, might expand goal
منابع مشابه
Evaluation of miR-101 Level in Patients with Chronic Hepatitis B Virus Infection and Liver Cirrhosis
ABSTRACT Background and Objective: MiRNAs are small RNAs that are expressed in most eukaryotes, and can regulate gene expression by attaching to the 3’ end of target mRNA. MicroRNA-101 (miR-101) post-transcriptional regulation is important for host-virus interactions. In addition, miR-101 has a tumor suppressive role in liver cancer and metastasis, an...
متن کاملPeginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis
BACKGROUND/AIMS Pegylated interferon (peginterferon) and ribavirin combination therapy is less effective and associated with a higher frequency of serious complications in chronic hepatitis C patients with cirrhosis than in noncirrhotic patients. This study evaluated the efficacy and tolerability of peginterferon and ribavirin treatment in patients with hepatitis C virus (HCV)-related cirrhosis...
متن کاملCohort study of the impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis Graham
متن کامل
Cirrhosis and liver transplantation in patients co-infected with HIV and hepatitis B or C: an observational cohort study
This study assessed the likelihood of referral for liver transplantation assessment in a prospective cohort of patients co-infected with HIV and hepatitis B or C with complications of cirrhosis. There were 141 co-infected patients from 11 UK centres with at least one complication of cirrhosis recorded (either decompensation or hepatocellular carcinoma) out of 772 identified with cirrhosis and/o...
متن کاملNew-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis
BACKGROUND Chronic hepatitis C is the most common cause of cirrhosis in industrialized countries. Successful treatment of chronic hepatitis C in patients with advanced fibrosis or cirrhosis has significant benefits, including improvements in inflammation, fibrosis, and portal hypertension, with prevention of esophageal varices and clinical decompensation. CASE In this report, we present two p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American journal of biomedicine
سال: 2023
ISSN: ['2333-5106']
DOI: https://doi.org/10.18081/2333-5106/2023.11/124